Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine vs placebo with intrathecal morphine for postoperative analgesia in major abdominal surgery
2025-521206-18-00Phase 3Authorised
- Sponsor
- Ramsay Santé Enseignement et Recherche
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Intravenous lidocaine arm with Placebo (sodium chloride) arm (2 arms). Primary endpoint: Total postoperative morphine consumption up to 48 hours. Planned start Jun 2025; status: authorised.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2025-521206-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521206-18-00.